What is the lethal dose of dexamphetamine (Amfexa) in a human?

Fatal Dose of AMFEXA (Dexamphetamine) in Humans

There is no definitively established lethal dose of dexamphetamine in humans, but reported fatalities have occurred with blood concentrations ranging from 0.27 to 13.51 μg/mL for amphetamines, with one case series reporting a lethal dose estimate of approximately 200 mg of methamphetamine (a closely related compound). However, lethality is highly variable and depends on individual tolerance, co-intoxicants, route of administration, and underlying medical conditions.

Critical Context from Available Evidence

The provided FDA drug label evidence 1 describes Amfexa as containing Guaifenesin 400 mg (an expectorant/cough suppressant), which is NOT dexamphetamine. This appears to be a labeling error or confusion with product naming. The actual AMFEXA product used for ADHD contains dexamphetamine sulfate.

What We Know About Dexamphetamine Lethality

Reported Lethal Doses and Blood Concentrations

• Methamphetamine reference point: One case series reported a lethal dose of approximately 200 mg for methamphetamine, though typical abuse doses range from 5-60 mg 2

• Amphetamine blood levels in fatalities: A forensic review found MDMA (a related amphetamine) blood concentrations in "pure" intoxication deaths ranging from 0.27 to 13.51 μg/mL, demonstrating extreme variability 3

• Safety ratio: Comparative toxicity research indicates intravenous heroin has the greatest direct physiological toxicity among abused substances, with amphetamines having intermediate toxicity 4

Therapeutic vs. Toxic Doses

Therapeutic dosing context 5:

• Maximum recommended daily dose: 40 mg total for amphetamines (per PDR)
• Some clinical practice extends to 0.9 mg/kg or up to 40 mg daily in adults
• Children <25 kg should not receive single doses >10 mg of dexamphetamine

The gap between therapeutic maximum (40 mg) and reported lethal doses (≥200 mg) suggests a safety margin of approximately 5-fold or greater, though this is highly individual.

Mechanisms of Fatal Toxicity

Amphetamine overdose causes death through multiple mechanisms 6, 3:

1. Acute cardiopulmonary failure (most common)

   • Excessive dopamine, norepinephrine, and serotonin release
   • Tachycardia, hypertension, arrhythmias
   • Cardiovascular collapse

2. Hyperthermia with secondary complications

   • Rhabdomyolysis
   • Acute kidney injury
   • Disseminated intravascular coagulation

3. Seizures leading to:

   • Status epilepticus
   • Respiratory failure
   • Cerebral edema

4. Serotonin syndrome in combination with other serotonergic agents

Critical Variables Affecting Lethality

Individual factors that dramatically alter lethal dose:

• Tolerance: Chronic users may tolerate doses that would be lethal to naive users
• Co-intoxicants: The majority of amphetamine fatalities involve alcohol or other drugs 3
• Route of administration: IV use has higher toxicity than oral 4
• Underlying cardiac disease: Pre-existing arrhythmias or hypertension increase risk
• Environmental factors: Hot environments exacerbate hyperthermia risk

Clinical Presentation of Severe Overdose

Expect the following in potentially lethal overdoses 6, 7:

• Neurological: Agitation, delirium, hallucinations, seizures, hyperthermia (>40°C)
• Cardiovascular: Severe tachycardia, hypertension (or paradoxical hypotension), arrhythmias
• Other: Mydriasis, diaphoresis, tremor, hyperreflexia, rhabdomyolysis

Management Priorities for Suspected Fatal Overdose

Immediate interventions 8, 6:

1. Benzodiazepines (first-line for agitation and seizures)

   • Control sympathomimetic syndrome
   • Prevent seizure-related complications

2. Aggressive cooling for hyperthermia

   • Target temperature <39°C

3. Cardiovascular support

   • Beta-blockers (propranolol) for tachyarrhythmias 9
   • Avoid pure alpha-agonists (may worsen hypertension)

4. Second-line agents if benzodiazepines fail:

   • Haloperidol (1-20 mg) 9
   • Propofol for refractory agitation
   • Dexmedetomidine for sympathetic overactivity

5. Supportive care

   • IV fluids for rhabdomyolysis
   • Monitor for acute kidney injury
   • Correct electrolyte abnormalities

Key Caveats

⚠️ There is no specific antidote for dexamphetamine overdose

⚠️ Blood levels correlate poorly with clinical severity - treat the patient, not the number 3

⚠️ Fatalities are rare with appropriate intensive care, even with massive overdoses 6

⚠️ Polydrug use is the rule, not the exception - always consider co-intoxicants 3

⚠️ Time from ingestion matters - sustained-release formulations may have delayed peak toxicity (tmax ~6 hours) 10